Menu
GeneBe

rs144655617

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000052.7(ATP7A):c.491G>A(p.Ser164Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000689 in 1,210,047 control chromosomes in the GnomAD database, including 3 homozygotes. There are 230 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S164C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0032 ( 1 hom., 96 hem., cov: 22)
Exomes 𝑓: 0.00043 ( 2 hom. 134 hem. )

Consequence

ATP7A
NM_000052.7 missense

Scores

2
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.13
Variant links:
Genes affected
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004740417).
BP6
Variant X-77988612-G-A is Benign according to our data. Variant chrX-77988612-G-A is described in ClinVar as [Benign]. Clinvar id is 465127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-77988612-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00322 (360/111900) while in subpopulation AFR AF= 0.011 (341/30883). AF 95% confidence interval is 0.0101. There are 1 homozygotes in gnomad4. There are 96 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd at 96 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ATP7ANM_000052.7 linkuse as main transcriptc.491G>A p.Ser164Asn missense_variant 3/23 ENST00000341514.11
ATP7ANM_001282224.2 linkuse as main transcriptc.491G>A p.Ser164Asn missense_variant 3/22
ATP7ANR_104109.2 linkuse as main transcriptn.284+16851G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ATP7AENST00000341514.11 linkuse as main transcriptc.491G>A p.Ser164Asn missense_variant 3/231 NM_000052.7 P1Q04656-1

Frequencies

GnomAD3 genomes
AF:
0.00322
AC:
360
AN:
111847
Hom.:
1
Cov.:
22
AF XY:
0.00282
AC XY:
96
AN XY:
34019
show subpopulations
Gnomad AFR
AF:
0.0111
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000384
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000226
Gnomad OTH
AF:
0.00199
GnomAD3 exomes
AF:
0.00103
AC:
189
AN:
183184
Hom.:
0
AF XY:
0.000857
AC XY:
58
AN XY:
67694
show subpopulations
Gnomad AFR exome
AF:
0.0124
Gnomad AMR exome
AF:
0.000474
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000135
Gnomad OTH exome
AF:
0.000442
GnomAD4 exome
AF:
0.000432
AC:
474
AN:
1098147
Hom.:
2
Cov.:
31
AF XY:
0.000369
AC XY:
134
AN XY:
363543
show subpopulations
Gnomad4 AFR exome
AF:
0.0127
Gnomad4 AMR exome
AF:
0.000511
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000950
Gnomad4 OTH exome
AF:
0.000759
GnomAD4 genome
AF:
0.00322
AC:
360
AN:
111900
Hom.:
1
Cov.:
22
AF XY:
0.00282
AC XY:
96
AN XY:
34084
show subpopulations
Gnomad4 AFR
AF:
0.0110
Gnomad4 AMR
AF:
0.000383
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000226
Gnomad4 OTH
AF:
0.00197
Alfa
AF:
0.000351
Hom.:
11
Bravo
AF:
0.00370
ESP6500AA
AF:
0.0115
AC:
44
ESP6500EA
AF:
0.000446
AC:
3
ExAC
AF:
0.00115
AC:
140
EpiCase
AF:
0.000164
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMay 19, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 18, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesFeb 14, 2020- -
Menkes kinky-hair syndrome;C0268353:Cutis laxa, X-linked;C1845359:X-linked distal spinal muscular atrophy type 3 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.41
Cadd
Benign
16
Dann
Benign
0.96
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.61
T;T
MetaRNN
Benign
0.0047
T;T
MetaSVM
Uncertain
0.0087
D
MutationAssessor
Benign
1.0
L;L
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.86
N;N
REVEL
Benign
0.24
Sift
Benign
0.085
T;T
Sift4G
Uncertain
0.037
D;D
Polyphen
0.0
.;B
Vest4
0.12
MVP
0.90
MPC
0.21
ClinPred
0.0019
T
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.073
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144655617; hg19: chrX-77244108; API